English

Plandai Biotechnology, Inc.

EDGAR

Report (type unavailable) · filed 2023-03-20

68 filing records in this dataset, filed from 2005-08-19 to 2023-03-20. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

100 thousand USD

2016 Q4 · USD

Exact inputs and evidence

Revenue: 100295 USD Source

Operating margin

-722.77%

2016 Q4 · %

Exact inputs and evidence

Operating Income: -724899 USD Source
Revenue: 100295 USD Source

Operating cash flow

-391 thousand USD

2016 Q4 · USD

Exact inputs and evidence

Operating Cash Flow: -828813 USD Source
Operating Cash Flow: -438003 USD Source

Free cash flow

-393 thousand USD

2016 Q4 · USD

Exact inputs and evidence

Operating Cash Flow: -828813 USD Source
Operating Cash Flow: -438003 USD Source
Capital Expenditure: 11379 USD Source
Capital Expenditure: 9513 USD Source

Cash and cash equivalents: 7.96 thousand USD 2016-03-31 Source
Exact value

7962 USD
Long-term debt including current maturities: 7.21 million USD 2013-03-31 Source
Exact value

7212182 USD
Shares outstanding: 180 million shares 2016-03-31 Source
Exact value

180406236 shares

Reported share-count change

12.39% · 19.9 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

160519936 shares · 2015-03-31· Source
180406236 shares · 2016-03-31· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

221 thousand USD

2015-04-01 – 2016-03-31

Exact inputs and evidence

Revenue: 92898 USD · 2014-07-01 – 2015-06-30 Source
Revenue: 64024 USD · 2014-07-01 – 2015-03-31 Source
Revenue: 40831 USD · 2015-07-01 – 2015-09-30 Source
Revenue: 50553 USD · 2015-10-01 – 2015-12-31 Source
Revenue: 100295 USD · 2016-01-01 – 2016-03-31 Source

Net income

-4.96 million USD

2015-04-01 – 2016-03-31

Exact inputs and evidence

Net income: -10072344 USD · 2014-07-01 – 2015-06-30 Source
Net income: -8145028 USD · 2014-07-01 – 2015-03-31 Source
Net income: -1189045 USD · 2015-07-01 – 2015-09-30 Source
Net income: -750269 USD · 2015-10-01 – 2015-12-31 Source
Net income: -1094811 USD · 2016-01-01 – 2016-03-31 Source

Capital expenditure

116 thousand USD

2015-04-01 – 2016-03-31

Exact inputs and evidence

Capital expenditure: 856853 USD · 2014-07-01 – 2015-06-30 Source
Capital expenditure: 752083 USD · 2014-07-01 – 2015-03-31 Source
Capital expenditure: 5769 USD · 2015-07-01 – 2015-09-30 Source
Capital expenditure: 9513 USD · 2015-07-01 – 2015-12-31 Source
Capital expenditure: 5769 USD · 2015-07-01 – 2015-09-30 Source
Capital expenditure: 11379 USD · 2015-07-01 – 2016-03-31 Source
Capital expenditure: 9513 USD · 2015-07-01 – 2015-12-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2023-03-20.

Financial data available through: 2015-06-30.

Financial coverage is incomplete. Newer filings are recorded, but comparable financial figures for those periods are not available here yet.

Coverage by financial measure

Revenue: 4 of 11 periods available· newest 2015-06-30
Operating income: 5 of 11 periods available· newest 2015-06-30
Net income: 10 of 11 periods available· newest 2015-06-30
Operating cash flow: 10 of 11 periods available· newest 2015-06-30
Capital expenditure: 6 of 11 periods available· newest 2015-06-30
Total assets: 4 of 11 periods available· newest 2015-06-30
Total liabilities: 4 of 11 periods available· newest 2015-06-30
Current assets: 4 of 11 periods available· newest 2015-06-30
Current liabilities: 4 of 11 periods available· newest 2015-06-30
Cash and cash equivalents: 4 of 11 periods available· newest 2015-06-30
Long-term debt including current maturities: 1 of 11 periods available· newest 2012-06-30
Shares outstanding: 4 of 11 periods available· newest 2015-06-30

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-65%

Prior period

USD 265,748

2013-07-01 – 2014-06-30
Current period

USD 92,898

2014-07-01 – 2015-06-30

Exact inputs and evidence

92898 − 265748 = -172850 USD

265748 USD · 2013-07-01 – 2014-06-30
Inspect prior input Prior source
92898 USD · 2014-07-01 – 2015-06-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · Plandai Biotechnology, Inc. · 2015-06-30 Plandai Biotechnology, Inc. (edgar:1317880) Year-over-year change in Revenue: -172850 USD Concept: fundies:Revenue Period: 2014-07-01 to 2015-06-30 Values: Latest reported Published: 2026-11-02T23:00:17Z Snapshot: b150735719fef50fdd2022f9a917bf50ccd7e36cde5facc12f2c97dcd64275d5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1317880?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 92898 USD (2014-07-01 to 2015-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1317880/000126246316000987/plpl-20150630.xml#176296 Filing: 000126246316000987 Input fundies:Revenue: 265748 USD (2013-07-01 to 2014-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1317880/000126246314000923/plpl-20140630.xml#122670 Filing: 000126246314000923
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 5.97 million

Prior period

−USD 16.05 million

2013-07-01 – 2014-06-30
Current period

−USD 10.07 million

2014-07-01 – 2015-06-30

Exact inputs and evidence

-10072344 − -16047112 = 5974768 USD

-16047112 USD · 2013-07-01 – 2014-06-30
Inspect prior input Prior source
-10072344 USD · 2014-07-01 – 2015-06-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · Plandai Biotechnology, Inc. · 2015-06-30 Plandai Biotechnology, Inc. (edgar:1317880) Year-over-year change in Net income: 5974768 USD Concept: fundies:NetIncome Period: 2014-07-01 to 2015-06-30 Values: Latest reported Published: 2026-11-02T23:00:17Z Snapshot: b150735719fef50fdd2022f9a917bf50ccd7e36cde5facc12f2c97dcd64275d5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1317880?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -10072344 USD (2014-07-01 to 2015-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1317880/000126246316000987/plpl-20150630.xml#144676 Filing: 000126246316000987 Input fundies:NetIncome: -16047112 USD (2013-07-01 to 2014-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1317880/000126246316000987/plpl-20150630.xml#145841 Filing: 000126246316000987
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 110,783

Prior period

−USD 2.59 million

2013-07-01 – 2014-06-30
Current period

−USD 2.7 million

2014-07-01 – 2015-06-30

Exact inputs and evidence

-2703939 − -2593156 = -110783 USD

-2593156 USD · 2013-07-01 – 2014-06-30
Inspect prior input Prior source
-2703939 USD · 2014-07-01 – 2015-06-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · Plandai Biotechnology, Inc. · 2015-06-30 Plandai Biotechnology, Inc. (edgar:1317880) Year-over-year change in Operating cash flow: -110783 USD Concept: fundies:OperatingCashFlow Period: 2014-07-01 to 2015-06-30 Values: Latest reported Published: 2026-11-02T23:00:17Z Snapshot: b150735719fef50fdd2022f9a917bf50ccd7e36cde5facc12f2c97dcd64275d5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1317880?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -2703939 USD (2014-07-01 to 2015-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1317880/000126246316000987/plpl-20150630.xml#183126 Filing: 000126246316000987 Input fundies:OperatingCashFlow: -2593156 USD (2013-07-01 to 2014-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1317880/000126246314000923/plpl-20140630.xml#138729 Filing: 000126246314000923
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-23.5%

Prior period

USD 1.12 million

2013-07-01 – 2014-06-30
Current period

USD 856,853

2014-07-01 – 2015-06-30

Exact inputs and evidence

856853 − 1119410 = -262557 USD

1119410 USD · 2013-07-01 – 2014-06-30
Inspect prior input Prior source
856853 USD · 2014-07-01 – 2015-06-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · Plandai Biotechnology, Inc. · 2015-06-30 Plandai Biotechnology, Inc. (edgar:1317880) Year-over-year change in Capital expenditure: -262557 USD Concept: fundies:CapitalExpenditure Period: 2014-07-01 to 2015-06-30 Values: Latest reported Published: 2026-11-02T23:00:17Z Snapshot: b150735719fef50fdd2022f9a917bf50ccd7e36cde5facc12f2c97dcd64275d5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1317880?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 856853 USD (2014-07-01 to 2015-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1317880/000126246316000987/plpl-20150630.xml#182724 Filing: 000126246316000987 Input fundies:CapitalExpenditure: 1119410 USD (2013-07-01 to 2014-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1317880/000126246314000923/plpl-20140630.xml#137813 Filing: 000126246314000923
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2016 2014-07-01 – 2015-06-30

Revenue USD 92,898 100% of revenue
Operating costs Derived USD 8.94 million 9,626% of revenue
Operating income −USD 8.85 million −9,526% of revenue
Tax, interest and other Derived USD 1.22 million 1,316% of revenue
Net income −USD 10.07 million −10,842% of revenue

Cash

Operating cash flow −USD 2.7 million −2,911% of revenue
Capital expenditure USD 856,853 922% of revenue
Free cash flow Derived −USD 3.56 million −3,833% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2013 Operating loss: operating costs were 5,217% of revenue.
2014 Operating loss: operating costs were 840% of revenue.
2015 Operating loss: operating costs were 3,093% of revenue.
2016 Operating loss: operating costs were 9,626% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2013 2011-07-01 – 2012-06-30	74452	3884226 Derived	-3809774	28586 Derived	-3838360	-1012133 Derived	Source 2011-07-01 – 2012-06-30: 74452 USD Inspect Revenue Open source 2011-07-01 – 2012-06-30: -3809774 USD Inspect Operating Income Open source 2011-07-01 – 2012-06-30: -3838360 USD Inspect Net Income Open source 2011-07-01 – 2012-06-30: -796296 USD Inspect Operating Cash Flow Open source 2011-07-01 – 2012-06-30: 215837 USD Inspect Capital Expenditure Open source
2014 2012-07-01 – 2013-06-30	359143	3016907 Derived	-2657764	310473 Derived	-2968237	-3806857 Derived	Source 2012-07-01 – 2013-06-30: 359143 USD Inspect Revenue Open source 2012-07-01 – 2013-06-30: -2657764 USD Inspect Operating Income Open source 2012-07-01 – 2013-06-30: -2968237 USD Inspect Net Income Open source 2012-07-01 – 2013-06-30: -1776735 USD Inspect Operating Cash Flow Open source 2012-07-01 – 2013-06-30: 2030122 USD Inspect Capital Expenditure Open source
2015 2013-07-01 – 2014-06-30	265748	8219225 Derived	-7953477	8093635 Derived	-16047112	-3712566 Derived	Source 2013-07-01 – 2014-06-30: 265748 USD Inspect Revenue Open source 2013-07-01 – 2014-06-30: -7953477 USD Inspect Operating Income Open source 2013-07-01 – 2014-06-30: -16047112 USD Inspect Net Income Open source 2013-07-01 – 2014-06-30: -2593156 USD Inspect Operating Cash Flow Open source 2013-07-01 – 2014-06-30: 1119410 USD Inspect Capital Expenditure Open source
2016 2014-07-01 – 2015-06-30	92898	8942465 Derived	-8849567	1222777 Derived	-10072344	-3560792 Derived	Source 2014-07-01 – 2015-06-30: 92898 USD Inspect Revenue Open source 2014-07-01 – 2015-06-30: -8849567 USD Inspect Operating Income Open source 2014-07-01 – 2015-06-30: -10072344 USD Inspect Net Income Open source 2014-07-01 – 2015-06-30: -2703939 USD Inspect Operating Cash Flow Open source 2014-07-01 – 2015-06-30: 856853 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 92.9K 2016

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20132012-06-30	Revenue	74452	Revenue: 74452 Open source
20142013-06-30	Revenue	359143	Revenue: 359143 Open source
20152014-06-30	Revenue	265748	Revenue: 265748 Open source
20162015-06-30	Revenue	92898	Revenue: 92898 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-65% 2016

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20132012-06-30	Year over year	No prior comparable period	Revenue: 74452 Open source
20142013-06-30	Year over year	382.4%	Revenue: 359143 Open source Revenue: 74452 Open source
20152014-06-30	Year over year	-26%	Revenue: 265748 Open source Revenue: 359143 Open source
20162015-06-30	Year over year	-65%	Revenue: 92898 Open source Revenue: 265748 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -9,526.1% 2016

Net margin -10,842.4% 2016

Free cash flow margin -3,833% 2016

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20132012-06-30	Operating margin	-5,117.1%	Operating Income: -3809774 Open source Revenue: 74452 Open source
20142013-06-30	Operating margin	-740%	Operating Income: -2657764 Open source Revenue: 359143 Open source
20152014-06-30	Operating margin	-2,992.9%	Operating Income: -7953477 Open source Revenue: 265748 Open source
20162015-06-30	Operating margin	-9,526.1%	Operating Income: -8849567 Open source Revenue: 92898 Open source
20132012-06-30	Net margin	-5,155.5%	Net Income: -3838360 Open source Revenue: 74452 Open source
20142013-06-30	Net margin	-826.5%	Net Income: -2968237 Open source Revenue: 359143 Open source
20152014-06-30	Net margin	-6,038.5%	Net Income: -16047112 Open source Revenue: 265748 Open source
20162015-06-30	Net margin	-10,842.4%	Net Income: -10072344 Open source Revenue: 92898 Open source
20132012-06-30	Free cash flow margin	-1,359.4%	Revenue: 74452 Open source Operating Cash Flow: -796296 Open source Capital Expenditure: 215837 Open source
20142013-06-30	Free cash flow margin	-1,060%	Revenue: 359143 Open source Operating Cash Flow: -1776735 Open source Capital Expenditure: 2030122 Open source
20152014-06-30	Free cash flow margin	-1,397%	Revenue: 265748 Open source Operating Cash Flow: -2593156 Open source Capital Expenditure: 1119410 Open source
20162015-06-30	Free cash flow margin	-3,833%	Revenue: 92898 Open source Operating Cash Flow: -2703939 Open source Capital Expenditure: 856853 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -2.7M 2016

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20132012-06-30	Operating cash flow	-796296	Operating Cash Flow: -796296 Open source
20142013-06-30	Operating cash flow	-1776735	Operating Cash Flow: -1776735 Open source
20152014-06-30	Operating cash flow	-2593156	Operating Cash Flow: -2593156 Open source
20162015-06-30	Operating cash flow	-2703939	Operating Cash Flow: -2703939 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -3.6M 2016

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20132012-06-30	Free cash flow	-1012133	Operating Cash Flow: -796296 Open source Capital Expenditure: 215837 Open source
20142013-06-30	Free cash flow	-3806857	Operating Cash Flow: -1776735 Open source Capital Expenditure: 2030122 Open source
20152014-06-30	Free cash flow	-3712566	Operating Cash Flow: -2593156 Open source Capital Expenditure: 1119410 Open source
20162015-06-30	Free cash flow	-3560792	Operating Cash Flow: -2703939 Open source Capital Expenditure: 856853 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

197.8% 2016

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20132012-06-30	Liabilities / assets	114.6%	Total Liabilities: 6939181 Open source Total Assets: 6057007 Open source
20142013-06-30	Liabilities / assets	139.4%	Total Liabilities: 12319844 Open source Total Assets: 8835482 Open source
20152014-06-30	Liabilities / assets	136.6%	Total Liabilities: 13222748 Open source Total Assets: 9683415 Open source
20162015-06-30	Liabilities / assets	197.8%	Total Liabilities: 16821317 Open source Total Assets: 8504581 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

0.03× 2016

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20132012-06-30	Current assets / current liabilities	0.05×	Current Assets: 5112 Open source Current Liabilities: 100481 Open source
20142013-06-30	Current assets / current liabilities	0.57×	Current Assets: 518994 Open source Current Liabilities: 903739 Open source
20152014-06-30	Current assets / current liabilities	2.62×	Current Assets: 593660 Open source Current Liabilities: 226900 Open source
20162015-06-30	Current assets / current liabilities	0.03×	Current Assets: 418159 Open source Current Liabilities: 15147347 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2006 2005-04-01 – 2006-03-31	−USD 597,454 Exact value Exact value: -597454 USD 2005-04-01 – 2006-03-31: -597454 USD Inspect Net Income Open source Share or cite Citation for Net Income · Plandai Biotechnology, Inc. · 2006-03-31 Plandai Biotechnology, Inc. (edgar:1317880) Net Income: -597454 USD Concept: fundies:NetIncome Period: 2005-04-01 to 2006-03-31 Values: Latest reported Published: 2026-11-02T23:00:17Z Snapshot: b150735719fef50fdd2022f9a917bf50ccd7e36cde5facc12f2c97dcd64275d5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1317880/explain?concept=fundies%3ANetIncome&period=2006-03-31&surface=latest&period_type=duration&start=2005-04-01&unit=USD&dimensions= Input fundies:NetIncome: -597454 USD (2005-04-01 to 2006-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1317880/0001262463-08-000102.txt#1550 The citation records this snapshot. The page link may show a newer release later.	−USD 580,040 Exact value Exact value: -580040 USD 2005-04-01 – 2006-03-31: -580040 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Plandai Biotechnology, Inc. · 2006-03-31 Plandai Biotechnology, Inc. (edgar:1317880) Operating Cash Flow: -580040 USD Concept: fundies:OperatingCashFlow Period: 2005-04-01 to 2006-03-31 Values: Latest reported Published: 2026-11-02T23:00:17Z Snapshot: b150735719fef50fdd2022f9a917bf50ccd7e36cde5facc12f2c97dcd64275d5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1317880/explain?concept=fundies%3AOperatingCashFlow&period=2006-03-31&surface=latest&period_type=duration&start=2005-04-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -580040 USD (2005-04-01 to 2006-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1317880/0001262463-08-000102.txt#1598 The citation records this snapshot. The page link may show a newer release later.	USD 57,644 Exact value Exact value: 57644 USD 2005-04-01 – 2006-03-31: 57644 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Plandai Biotechnology, Inc. · 2006-03-31 Plandai Biotechnology, Inc. (edgar:1317880) Capital Expenditure: 57644 USD Concept: fundies:CapitalExpenditure Period: 2005-04-01 to 2006-03-31 Values: Latest reported Published: 2026-11-02T23:00:17Z Snapshot: b150735719fef50fdd2022f9a917bf50ccd7e36cde5facc12f2c97dcd64275d5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1317880/explain?concept=fundies%3ACapitalExpenditure&period=2006-03-31&surface=latest&period_type=duration&start=2005-04-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 57644 USD (2005-04-01 to 2006-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1317880/0000939802-06-000399.txt#2169 The citation records this snapshot. The page link may show a newer release later.	−USD 637,684 Calculation and evidence -580040 − 57644 USD Exact free cash flow: -637684 USD 2005-04-01 – 2006-03-31: -580040 USD · Inspect Operating Cash Flow · Source 2005-04-01 – 2006-03-31: 57644 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Plandai Biotechnology, Inc. · 2006-03-31 Plandai Biotechnology, Inc. (edgar:1317880) Free cash flow: -637684 USD Concept: free-cash-flow Period: 2005-04-01 to 2006-03-31 Values: Latest reported Published: 2026-11-02T23:00:17Z Snapshot: b150735719fef50fdd2022f9a917bf50ccd7e36cde5facc12f2c97dcd64275d5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1317880?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -580040 USD (2005-04-01 to 2006-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1317880/0001262463-08-000102.txt#1598 Input fundies:CapitalExpenditure: 57644 USD (2005-04-01 to 2006-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1317880/0000939802-06-000399.txt#2169 The citation records this snapshot. The page link may show a newer release later.
2007 2006-04-01 – 2007-03-31	−USD 979,168 Exact value Exact value: -979168 USD 2006-04-01 – 2007-03-31: -979168 USD Inspect Net Income Open source Share or cite Citation for Net Income · Plandai Biotechnology, Inc. · 2007-03-31 Plandai Biotechnology, Inc. (edgar:1317880) Net Income: -979168 USD Concept: fundies:NetIncome Period: 2006-04-01 to 2007-03-31 Values: Latest reported Published: 2026-11-02T23:00:17Z Snapshot: b150735719fef50fdd2022f9a917bf50ccd7e36cde5facc12f2c97dcd64275d5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1317880/explain?concept=fundies%3ANetIncome&period=2007-03-31&surface=latest&period_type=duration&start=2006-04-01&unit=USD&dimensions= Input fundies:NetIncome: -979168 USD (2006-04-01 to 2007-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1317880/0001262463-08-000102.txt#1550 The citation records this snapshot. The page link may show a newer release later.	−USD 1.22 million Exact value Exact value: -1219050 USD 2006-04-01 – 2007-03-31: -1219050 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Plandai Biotechnology, Inc. · 2007-03-31 Plandai Biotechnology, Inc. (edgar:1317880) Operating Cash Flow: -1219050 USD Concept: fundies:OperatingCashFlow Period: 2006-04-01 to 2007-03-31 Values: Latest reported Published: 2026-11-02T23:00:17Z Snapshot: b150735719fef50fdd2022f9a917bf50ccd7e36cde5facc12f2c97dcd64275d5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1317880/explain?concept=fundies%3AOperatingCashFlow&period=2007-03-31&surface=latest&period_type=duration&start=2006-04-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1219050 USD (2006-04-01 to 2007-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1317880/0001262463-08-000102.txt#1598 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2008 2007-04-01 – 2008-03-31	−USD 1.89 million Exact value Exact value: -1894010 USD 2007-04-01 – 2008-03-31: -1894010 USD Inspect Net Income Open source Share or cite Citation for Net Income · Plandai Biotechnology, Inc. · 2008-03-31 Plandai Biotechnology, Inc. (edgar:1317880) Net Income: -1894010 USD Concept: fundies:NetIncome Period: 2007-04-01 to 2008-03-31 Values: Latest reported Published: 2026-11-02T23:00:17Z Snapshot: b150735719fef50fdd2022f9a917bf50ccd7e36cde5facc12f2c97dcd64275d5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1317880/explain?concept=fundies%3ANetIncome&period=2008-03-31&surface=latest&period_type=duration&start=2007-04-01&unit=USD&dimensions= Input fundies:NetIncome: -1894010 USD (2007-04-01 to 2008-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1317880/0001262463-10-000088.txt#1940 The citation records this snapshot. The page link may show a newer release later.	−USD 442,019 Exact value Exact value: -442019 USD 2007-04-01 – 2008-03-31: -442019 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Plandai Biotechnology, Inc. · 2008-03-31 Plandai Biotechnology, Inc. (edgar:1317880) Operating Cash Flow: -442019 USD Concept: fundies:OperatingCashFlow Period: 2007-04-01 to 2008-03-31 Values: Latest reported Published: 2026-11-02T23:00:17Z Snapshot: b150735719fef50fdd2022f9a917bf50ccd7e36cde5facc12f2c97dcd64275d5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1317880/explain?concept=fundies%3AOperatingCashFlow&period=2008-03-31&surface=latest&period_type=duration&start=2007-04-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -442019 USD (2007-04-01 to 2008-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1317880/0001262463-10-000088.txt#2008 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2009 2008-04-01 – 2009-03-31	−USD 825,401 Exact value Exact value: -825401 USD 2008-04-01 – 2009-03-31: -825401 USD Inspect Net Income Open source Share or cite Citation for Net Income · Plandai Biotechnology, Inc. · 2009-03-31 Plandai Biotechnology, Inc. (edgar:1317880) Net Income: -825401 USD Concept: fundies:NetIncome Period: 2008-04-01 to 2009-03-31 Values: Latest reported Published: 2026-11-02T23:00:17Z Snapshot: b150735719fef50fdd2022f9a917bf50ccd7e36cde5facc12f2c97dcd64275d5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1317880/explain?concept=fundies%3ANetIncome&period=2009-03-31&surface=latest&period_type=duration&start=2008-04-01&unit=USD&dimensions= Input fundies:NetIncome: -825401 USD (2008-04-01 to 2009-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1317880/0001262463-10-000088.txt#1940 The citation records this snapshot. The page link may show a newer release later.	USD 172,150 Exact value Exact value: 172150 USD 2008-04-01 – 2009-03-31: 172150 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Plandai Biotechnology, Inc. · 2009-03-31 Plandai Biotechnology, Inc. (edgar:1317880) Operating Cash Flow: 172150 USD Concept: fundies:OperatingCashFlow Period: 2008-04-01 to 2009-03-31 Values: Latest reported Published: 2026-11-02T23:00:17Z Snapshot: b150735719fef50fdd2022f9a917bf50ccd7e36cde5facc12f2c97dcd64275d5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1317880/explain?concept=fundies%3AOperatingCashFlow&period=2009-03-31&surface=latest&period_type=duration&start=2008-04-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 172150 USD (2008-04-01 to 2009-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1317880/0001262463-10-000088.txt#2008 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2010 2009-07-01 – 2010-06-30	−USD 2.26 million Exact value Exact value: -2263890 USD 2009-07-01 – 2010-06-30: -2263890 USD Inspect Net Income Open source Share or cite Citation for Net Income · Plandai Biotechnology, Inc. · 2010-06-30 Plandai Biotechnology, Inc. (edgar:1317880) Net Income: -2263890 USD Concept: fundies:NetIncome Period: 2009-07-01 to 2010-06-30 Values: Latest reported Published: 2026-11-02T23:00:17Z Snapshot: b150735719fef50fdd2022f9a917bf50ccd7e36cde5facc12f2c97dcd64275d5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1317880/explain?concept=fundies%3ANetIncome&period=2010-06-30&surface=latest&period_type=duration&start=2009-07-01&unit=USD&dimensions= Input fundies:NetIncome: -2263890 USD (2009-07-01 to 2010-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1317880/0001262463-10-000088.txt#1940 The citation records this snapshot. The page link may show a newer release later.	−USD 811,899 Exact value Exact value: -811899 USD 2009-07-01 – 2010-06-30: -811899 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Plandai Biotechnology, Inc. · 2010-06-30 Plandai Biotechnology, Inc. (edgar:1317880) Operating Cash Flow: -811899 USD Concept: fundies:OperatingCashFlow Period: 2009-07-01 to 2010-06-30 Values: Latest reported Published: 2026-11-02T23:00:17Z Snapshot: b150735719fef50fdd2022f9a917bf50ccd7e36cde5facc12f2c97dcd64275d5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1317880/explain?concept=fundies%3AOperatingCashFlow&period=2010-06-30&surface=latest&period_type=duration&start=2009-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -811899 USD (2009-07-01 to 2010-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1317880/0001262463-10-000088.txt#2008 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2012 2010-07-01 – 2011-06-30	−USD 84,751 Exact value Exact value: -84751 USD 2010-07-01 – 2011-06-30: -84751 USD Inspect Net Income Open source Share or cite Citation for Net Income · Plandai Biotechnology, Inc. · 2011-06-30 Plandai Biotechnology, Inc. (edgar:1317880) Net Income: -84751 USD Concept: fundies:NetIncome Period: 2010-07-01 to 2011-06-30 Values: Latest reported Published: 2026-11-02T23:00:17Z Snapshot: b150735719fef50fdd2022f9a917bf50ccd7e36cde5facc12f2c97dcd64275d5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1317880/explain?concept=fundies%3ANetIncome&period=2011-06-30&surface=latest&period_type=duration&start=2010-07-01&unit=USD&dimensions= Input fundies:NetIncome: -84751 USD (2010-07-01 to 2011-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1317880/000126246312000394/fil-20120630.xml#41162 Filing: 000126246312000394 The citation records this snapshot. The page link may show a newer release later.	USD 134 Exact value Exact value: 134 USD 2010-07-01 – 2011-06-30: 134 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Plandai Biotechnology, Inc. · 2011-06-30 Plandai Biotechnology, Inc. (edgar:1317880) Operating Cash Flow: 134 USD Concept: fundies:OperatingCashFlow Period: 2010-07-01 to 2011-06-30 Values: Latest reported Published: 2026-11-02T23:00:17Z Snapshot: b150735719fef50fdd2022f9a917bf50ccd7e36cde5facc12f2c97dcd64275d5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1317880/explain?concept=fundies%3AOperatingCashFlow&period=2011-06-30&surface=latest&period_type=duration&start=2010-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 134 USD (2010-07-01 to 2011-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1317880/000126246312000394/fil-20120630.xml#46656 Filing: 000126246312000394 The citation records this snapshot. The page link may show a newer release later.	USD 0 Exact value Exact value: 0 USD 2010-07-01 – 2011-06-30: 0 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Plandai Biotechnology, Inc. · 2011-06-30 Plandai Biotechnology, Inc. (edgar:1317880) Capital Expenditure: 0 USD Concept: fundies:CapitalExpenditure Period: 2010-07-01 to 2011-06-30 Values: Latest reported Published: 2026-11-02T23:00:17Z Snapshot: b150735719fef50fdd2022f9a917bf50ccd7e36cde5facc12f2c97dcd64275d5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1317880/explain?concept=fundies%3ACapitalExpenditure&period=2011-06-30&surface=latest&period_type=duration&start=2010-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 0 USD (2010-07-01 to 2011-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1317880/000126246312000394/fil-20120630.xml#47019 Filing: 000126246312000394 The citation records this snapshot. The page link may show a newer release later.	USD 134 Calculation and evidence 134 − 0 USD Exact free cash flow: 134 USD 2010-07-01 – 2011-06-30: 134 USD · Inspect Operating Cash Flow · Source 2010-07-01 – 2011-06-30: 0 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Plandai Biotechnology, Inc. · 2011-06-30 Plandai Biotechnology, Inc. (edgar:1317880) Free cash flow: 134 USD Concept: free-cash-flow Period: 2010-07-01 to 2011-06-30 Values: Latest reported Published: 2026-11-02T23:00:17Z Snapshot: b150735719fef50fdd2022f9a917bf50ccd7e36cde5facc12f2c97dcd64275d5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1317880?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 134 USD (2010-07-01 to 2011-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1317880/000126246312000394/fil-20120630.xml#46656 Filing: 000126246312000394 Input fundies:CapitalExpenditure: 0 USD (2010-07-01 to 2011-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1317880/000126246312000394/fil-20120630.xml#47019 Filing: 000126246312000394 The citation records this snapshot. The page link may show a newer release later.
2013 2011-07-01 – 2012-06-30	−USD 3.84 million Exact value Exact value: -3838360 USD 2011-07-01 – 2012-06-30: -3838360 USD Inspect Net Income Open source Share or cite Citation for Net Income · Plandai Biotechnology, Inc. · 2012-06-30 Plandai Biotechnology, Inc. (edgar:1317880) Net Income: -3838360 USD Concept: fundies:NetIncome Period: 2011-07-01 to 2012-06-30 Values: Latest reported Published: 2026-11-02T23:00:17Z Snapshot: b150735719fef50fdd2022f9a917bf50ccd7e36cde5facc12f2c97dcd64275d5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1317880/explain?concept=fundies%3ANetIncome&period=2012-06-30&surface=latest&period_type=duration&start=2011-07-01&unit=USD&dimensions= Input fundies:NetIncome: -3838360 USD (2011-07-01 to 2012-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1317880/000126246314000362/fil-20130630.xml#73462 Filing: 000126246314000362 The citation records this snapshot. The page link may show a newer release later.	−USD 796,296 Exact value Exact value: -796296 USD 2011-07-01 – 2012-06-30: -796296 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Plandai Biotechnology, Inc. · 2012-06-30 Plandai Biotechnology, Inc. (edgar:1317880) Operating Cash Flow: -796296 USD Concept: fundies:OperatingCashFlow Period: 2011-07-01 to 2012-06-30 Values: Latest reported Published: 2026-11-02T23:00:17Z Snapshot: b150735719fef50fdd2022f9a917bf50ccd7e36cde5facc12f2c97dcd64275d5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1317880/explain?concept=fundies%3AOperatingCashFlow&period=2012-06-30&surface=latest&period_type=duration&start=2011-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -796296 USD (2011-07-01 to 2012-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1317880/000126246314000362/fil-20130630.xml#77294 Filing: 000126246314000362 The citation records this snapshot. The page link may show a newer release later.	USD 215,837 Exact value Exact value: 215837 USD 2011-07-01 – 2012-06-30: 215837 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Plandai Biotechnology, Inc. · 2012-06-30 Plandai Biotechnology, Inc. (edgar:1317880) Capital Expenditure: 215837 USD Concept: fundies:CapitalExpenditure Period: 2011-07-01 to 2012-06-30 Values: Latest reported Published: 2026-11-02T23:00:17Z Snapshot: b150735719fef50fdd2022f9a917bf50ccd7e36cde5facc12f2c97dcd64275d5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1317880/explain?concept=fundies%3ACapitalExpenditure&period=2012-06-30&surface=latest&period_type=duration&start=2011-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 215837 USD (2011-07-01 to 2012-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1317880/000126246314000362/fil-20130630.xml#84350 Filing: 000126246314000362 The citation records this snapshot. The page link may show a newer release later.	−USD 1.01 million Calculation and evidence -796296 − 215837 USD Exact free cash flow: -1012133 USD 2011-07-01 – 2012-06-30: -796296 USD · Inspect Operating Cash Flow · Source 2011-07-01 – 2012-06-30: 215837 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Plandai Biotechnology, Inc. · 2012-06-30 Plandai Biotechnology, Inc. (edgar:1317880) Free cash flow: -1012133 USD Concept: free-cash-flow Period: 2011-07-01 to 2012-06-30 Values: Latest reported Published: 2026-11-02T23:00:17Z Snapshot: b150735719fef50fdd2022f9a917bf50ccd7e36cde5facc12f2c97dcd64275d5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1317880?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -796296 USD (2011-07-01 to 2012-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1317880/000126246314000362/fil-20130630.xml#77294 Filing: 000126246314000362 Input fundies:CapitalExpenditure: 215837 USD (2011-07-01 to 2012-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1317880/000126246314000362/fil-20130630.xml#84350 Filing: 000126246314000362 The citation records this snapshot. The page link may show a newer release later.
2014 2012-07-01 – 2013-06-30	−USD 2.97 million Exact value Exact value: -2968237 USD 2012-07-01 – 2013-06-30: -2968237 USD Inspect Net Income Open source Share or cite Citation for Net Income · Plandai Biotechnology, Inc. · 2013-06-30 Plandai Biotechnology, Inc. (edgar:1317880) Net Income: -2968237 USD Concept: fundies:NetIncome Period: 2012-07-01 to 2013-06-30 Values: Latest reported Published: 2026-11-02T23:00:17Z Snapshot: b150735719fef50fdd2022f9a917bf50ccd7e36cde5facc12f2c97dcd64275d5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1317880/explain?concept=fundies%3ANetIncome&period=2013-06-30&surface=latest&period_type=duration&start=2012-07-01&unit=USD&dimensions= Input fundies:NetIncome: -2968237 USD (2012-07-01 to 2013-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1317880/000126246314000923/plpl-20140630.xml#128859 Filing: 000126246314000923 The citation records this snapshot. The page link may show a newer release later.	−USD 1.78 million Exact value Exact value: -1776735 USD 2012-07-01 – 2013-06-30: -1776735 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Plandai Biotechnology, Inc. · 2013-06-30 Plandai Biotechnology, Inc. (edgar:1317880) Operating Cash Flow: -1776735 USD Concept: fundies:OperatingCashFlow Period: 2012-07-01 to 2013-06-30 Values: Latest reported Published: 2026-11-02T23:00:17Z Snapshot: b150735719fef50fdd2022f9a917bf50ccd7e36cde5facc12f2c97dcd64275d5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1317880/explain?concept=fundies%3AOperatingCashFlow&period=2013-06-30&surface=latest&period_type=duration&start=2012-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1776735 USD (2012-07-01 to 2013-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1317880/000126246314000923/plpl-20140630.xml#138544 Filing: 000126246314000923 The citation records this snapshot. The page link may show a newer release later.	USD 2.03 million Exact value Exact value: 2030122 USD 2012-07-01 – 2013-06-30: 2030122 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Plandai Biotechnology, Inc. · 2013-06-30 Plandai Biotechnology, Inc. (edgar:1317880) Capital Expenditure: 2030122 USD Concept: fundies:CapitalExpenditure Period: 2012-07-01 to 2013-06-30 Values: Latest reported Published: 2026-11-02T23:00:17Z Snapshot: b150735719fef50fdd2022f9a917bf50ccd7e36cde5facc12f2c97dcd64275d5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1317880/explain?concept=fundies%3ACapitalExpenditure&period=2013-06-30&surface=latest&period_type=duration&start=2012-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2030122 USD (2012-07-01 to 2013-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1317880/000126246314000923/plpl-20140630.xml#137629 Filing: 000126246314000923 The citation records this snapshot. The page link may show a newer release later.	−USD 3.81 million Calculation and evidence -1776735 − 2030122 USD Exact free cash flow: -3806857 USD 2012-07-01 – 2013-06-30: -1776735 USD · Inspect Operating Cash Flow · Source 2012-07-01 – 2013-06-30: 2030122 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Plandai Biotechnology, Inc. · 2013-06-30 Plandai Biotechnology, Inc. (edgar:1317880) Free cash flow: -3806857 USD Concept: free-cash-flow Period: 2012-07-01 to 2013-06-30 Values: Latest reported Published: 2026-11-02T23:00:17Z Snapshot: b150735719fef50fdd2022f9a917bf50ccd7e36cde5facc12f2c97dcd64275d5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1317880?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -1776735 USD (2012-07-01 to 2013-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1317880/000126246314000923/plpl-20140630.xml#138544 Filing: 000126246314000923 Input fundies:CapitalExpenditure: 2030122 USD (2012-07-01 to 2013-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1317880/000126246314000923/plpl-20140630.xml#137629 Filing: 000126246314000923 The citation records this snapshot. The page link may show a newer release later.
2015 2013-07-01 – 2014-06-30	−USD 16.05 million Exact value Exact value: -16047112 USD 2013-07-01 – 2014-06-30: -16047112 USD Inspect Net Income Open source Share or cite Citation for Net Income · Plandai Biotechnology, Inc. · 2014-06-30 Plandai Biotechnology, Inc. (edgar:1317880) Net Income: -16047112 USD Concept: fundies:NetIncome Period: 2013-07-01 to 2014-06-30 Values: Latest reported Published: 2026-11-02T23:00:17Z Snapshot: b150735719fef50fdd2022f9a917bf50ccd7e36cde5facc12f2c97dcd64275d5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1317880/explain?concept=fundies%3ANetIncome&period=2014-06-30&surface=latest&period_type=duration&start=2013-07-01&unit=USD&dimensions= Input fundies:NetIncome: -16047112 USD (2013-07-01 to 2014-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1317880/000126246316000987/plpl-20150630.xml#145841 Filing: 000126246316000987 The citation records this snapshot. The page link may show a newer release later.	−USD 2.59 million Exact value Exact value: -2593156 USD 2013-07-01 – 2014-06-30: -2593156 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Plandai Biotechnology, Inc. · 2014-06-30 Plandai Biotechnology, Inc. (edgar:1317880) Operating Cash Flow: -2593156 USD Concept: fundies:OperatingCashFlow Period: 2013-07-01 to 2014-06-30 Values: Latest reported Published: 2026-11-02T23:00:17Z Snapshot: b150735719fef50fdd2022f9a917bf50ccd7e36cde5facc12f2c97dcd64275d5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1317880/explain?concept=fundies%3AOperatingCashFlow&period=2014-06-30&surface=latest&period_type=duration&start=2013-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -2593156 USD (2013-07-01 to 2014-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1317880/000126246314000923/plpl-20140630.xml#138729 Filing: 000126246314000923 The citation records this snapshot. The page link may show a newer release later.	USD 1.12 million Exact value Exact value: 1119410 USD 2013-07-01 – 2014-06-30: 1119410 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Plandai Biotechnology, Inc. · 2014-06-30 Plandai Biotechnology, Inc. (edgar:1317880) Capital Expenditure: 1119410 USD Concept: fundies:CapitalExpenditure Period: 2013-07-01 to 2014-06-30 Values: Latest reported Published: 2026-11-02T23:00:17Z Snapshot: b150735719fef50fdd2022f9a917bf50ccd7e36cde5facc12f2c97dcd64275d5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1317880/explain?concept=fundies%3ACapitalExpenditure&period=2014-06-30&surface=latest&period_type=duration&start=2013-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1119410 USD (2013-07-01 to 2014-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1317880/000126246314000923/plpl-20140630.xml#137813 Filing: 000126246314000923 The citation records this snapshot. The page link may show a newer release later.	−USD 3.71 million Calculation and evidence -2593156 − 1119410 USD Exact free cash flow: -3712566 USD 2013-07-01 – 2014-06-30: -2593156 USD · Inspect Operating Cash Flow · Source 2013-07-01 – 2014-06-30: 1119410 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Plandai Biotechnology, Inc. · 2014-06-30 Plandai Biotechnology, Inc. (edgar:1317880) Free cash flow: -3712566 USD Concept: free-cash-flow Period: 2013-07-01 to 2014-06-30 Values: Latest reported Published: 2026-11-02T23:00:17Z Snapshot: b150735719fef50fdd2022f9a917bf50ccd7e36cde5facc12f2c97dcd64275d5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1317880?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -2593156 USD (2013-07-01 to 2014-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1317880/000126246314000923/plpl-20140630.xml#138729 Filing: 000126246314000923 Input fundies:CapitalExpenditure: 1119410 USD (2013-07-01 to 2014-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1317880/000126246314000923/plpl-20140630.xml#137813 Filing: 000126246314000923 The citation records this snapshot. The page link may show a newer release later.
2016 2014-07-01 – 2015-06-30	−USD 10.07 million Exact value Exact value: -10072344 USD 2014-07-01 – 2015-06-30: -10072344 USD Inspect Net Income Open source Share or cite Citation for Net Income · Plandai Biotechnology, Inc. · 2015-06-30 Plandai Biotechnology, Inc. (edgar:1317880) Net Income: -10072344 USD Concept: fundies:NetIncome Period: 2014-07-01 to 2015-06-30 Values: Latest reported Published: 2026-11-02T23:00:17Z Snapshot: b150735719fef50fdd2022f9a917bf50ccd7e36cde5facc12f2c97dcd64275d5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1317880/explain?concept=fundies%3ANetIncome&period=2015-06-30&surface=latest&period_type=duration&start=2014-07-01&unit=USD&dimensions= Input fundies:NetIncome: -10072344 USD (2014-07-01 to 2015-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1317880/000126246316000987/plpl-20150630.xml#144676 Filing: 000126246316000987 The citation records this snapshot. The page link may show a newer release later.	−USD 2.7 million Exact value Exact value: -2703939 USD 2014-07-01 – 2015-06-30: -2703939 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Plandai Biotechnology, Inc. · 2015-06-30 Plandai Biotechnology, Inc. (edgar:1317880) Operating Cash Flow: -2703939 USD Concept: fundies:OperatingCashFlow Period: 2014-07-01 to 2015-06-30 Values: Latest reported Published: 2026-11-02T23:00:17Z Snapshot: b150735719fef50fdd2022f9a917bf50ccd7e36cde5facc12f2c97dcd64275d5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1317880/explain?concept=fundies%3AOperatingCashFlow&period=2015-06-30&surface=latest&period_type=duration&start=2014-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -2703939 USD (2014-07-01 to 2015-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1317880/000126246316000987/plpl-20150630.xml#183126 Filing: 000126246316000987 The citation records this snapshot. The page link may show a newer release later.	USD 856,853 Exact value Exact value: 856853 USD 2014-07-01 – 2015-06-30: 856853 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Plandai Biotechnology, Inc. · 2015-06-30 Plandai Biotechnology, Inc. (edgar:1317880) Capital Expenditure: 856853 USD Concept: fundies:CapitalExpenditure Period: 2014-07-01 to 2015-06-30 Values: Latest reported Published: 2026-11-02T23:00:17Z Snapshot: b150735719fef50fdd2022f9a917bf50ccd7e36cde5facc12f2c97dcd64275d5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1317880/explain?concept=fundies%3ACapitalExpenditure&period=2015-06-30&surface=latest&period_type=duration&start=2014-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 856853 USD (2014-07-01 to 2015-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1317880/000126246316000987/plpl-20150630.xml#182724 Filing: 000126246316000987 The citation records this snapshot. The page link may show a newer release later.	−USD 3.56 million Calculation and evidence -2703939 − 856853 USD Exact free cash flow: -3560792 USD 2014-07-01 – 2015-06-30: -2703939 USD · Inspect Operating Cash Flow · Source 2014-07-01 – 2015-06-30: 856853 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Plandai Biotechnology, Inc. · 2015-06-30 Plandai Biotechnology, Inc. (edgar:1317880) Free cash flow: -3560792 USD Concept: free-cash-flow Period: 2014-07-01 to 2015-06-30 Values: Latest reported Published: 2026-11-02T23:00:17Z Snapshot: b150735719fef50fdd2022f9a917bf50ccd7e36cde5facc12f2c97dcd64275d5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1317880?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -2703939 USD (2014-07-01 to 2015-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1317880/000126246316000987/plpl-20150630.xml#183126 Filing: 000126246316000987 Input fundies:CapitalExpenditure: 856853 USD (2014-07-01 to 2015-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1317880/000126246316000987/plpl-20150630.xml#182724 Filing: 000126246316000987 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

68 filings · 1,430 latest values · 1,430 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001317880, 1317880, edgar:1317880

Also known as Diamond Ranch Foods, Ltd., NEW, Plandai Biotechnology, Inc.

Plandai Biotechnology, Inc.

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Capital expenditure

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2016 2014-07-01 – 2015-06-30

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation